sprycel - dasatinib tablet
(Dasatinib)E.R. Squibb & Sons, L.L.C.
Usage: Sprycel treats Ph+ chronic myeloid leukemia (CML) in adults—newly diagnosed or resistant/intolerant to prior therapy—and Ph+ acute lymphoblastic leukemia (Ph+ ALL). Also indicated for pediatric patients aged 1 year and older with Ph+ CML in chronic phase, and newly diagnosed Ph+ ALL with chemotherapy.